Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma |
| |
Authors: | Myriam Sasanelli Michel Meignan Corinne Haioun Alina Berriolo-Riedinger René-Olivier Casasnovas Alberto Biggi Andrea Gallamini Barry A Siegel Amanda F Cashen Pierre Véra Hervé Tilly Annibale Versari Emmanuel Itti |
| |
Institution: | 1. Nuclear Medicine and Lymphoid Malignancies Unit, Henri Mondor Hospital, Paris-Est University, 51 Ave. du Mal de Lattre, 94010, Créteil, France 2. Nuclear Medicine and Hematology, Georges-Fran?ois Leclerc Center, Le Bocage Hospital, Dijon, France 3. Nuclear Medicine and Hematology, Santa Croce e Carle Hospital, Cuneo, Italy 4. Nuclear Medicine and Oncology, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA 5. Nuclear Medicine and Hematology, Henri Becquerel Center, Rouen, France 6. Nuclear Medicine, Santa Maria Nuova Hospital-IRCCS, Reggio Emilia, Italy
|
| |
Abstract: | Purpose We investigated the prognostic value of total metabolic tumour volume (TMTV) in diffuse large B-cell lymphoma (DLBCL). Methods TMTV was measured in 114 patients with newly diagnosed DLBCL who underwent 18F-FDG PET/CT at baseline before immunochemotherapy. TMTV was computed by summing the volumes of all lymphomatous lesions after applying the local SUVmax threshold of 41 % using semiautomatic software. Prognostic value was assessed by Kaplan-Meier estimates of progression-free survival (PFS) and overall survival (OS). Results Median follow-up was 39 months. Average pretherapy TMTV was 509?±?568 cm3. The 3-year estimates of PFS were 77 % in the low metabolic burden group (TMTV ≤550 cm3) and 60 % in the high metabolic burden group (TMTV >550 cm3, p?=?0.04), and prediction of OS was even better (87 % vs. 60 %, p?=?0.0003). Cox regression showed independence of TMTV for OS prediction (p?=?0.002) compared with other pretherapy indices of tumour burden, such as tumour bulk and the International Prognostic Index. Conclusion Pretherapy TMTV is an independent predictor of outcome in patients with DLBCL. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|